Literature DB >> 34737034

Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology, and Management.

Luke R Gagnon1, Chandu Sadasivan1, Kevin Perera1, Gavin Y Oudit2.   

Abstract

Cardiovascular complications from drugs of abuse are becoming more apparent because of increased usage worldwide. Substance abuse can cause acute and chronic cardiovascular complications and is increasing in prevalence especially in young adults. These substances contribute to the development of acute coronary syndrome, type 2 myocardial injury, arrhythmias, and cardiomyopathies, and have numerous other cardiovascular complications. Although no screening guidelines exist, clinical awareness of these potential complications and their prevention, clinical presentation, diagnosis, and treatment are critically important. Management of cardiovascular disease should be coupled with appropriate social and mental health interventions to provide sustained clinical benefit. The higher the number of substances used recreationally, the greater the risk of premature heart disease. Epidemiological studies showed that 1 in 5 young adults misuse several substances and often start using at younger ages with a greater risk for adverse health outcomes over the long term. The aim of this review is to highlight the basic epidemiology, cardiac complications, and disease-specific treatment options of commonly abused substances including methamphetamine, cocaine, alcohol, anabolic-androgenic steroids, cannabis, and tobacco.
Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34737034     DOI: 10.1016/j.cjca.2021.10.008

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   6.614


  2 in total

1.  Anabolic steroid misuse is an important reversible cause of cardiomyopathy: a case report.

Authors:  Stefan V Milevski; Matthew Sawyer; Andre La Gerche; Elizabeth Paratz
Journal:  Eur Heart J Case Rep       Date:  2022-07-02

Review 2.  Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.

Authors:  Luke R Gagnon; Chandu Sadasivan; Haran Yogasundaram; Gavin Y Oudit
Journal:  Curr Heart Fail Rep       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.